TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Sees Significant Decrease in Short Interest

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 157,200 shares, a drop of 48.3% from the November 15th total of 304,300 shares. Based on an average daily volume of 1,350,000 shares, the short-interest ratio is currently 0.1 days. Currently, 4.0% of the shares of the company are sold short.

TFF Pharmaceuticals Price Performance

Shares of TFFP remained flat at $0.07 during trading hours on Friday. The company has a 50-day moving average price of $1.31 and a 200 day moving average price of $1.72. TFF Pharmaceuticals has a 1-year low of $0.06 and a 1-year high of $11.00. The stock has a market capitalization of $288,795.00, a price-to-earnings ratio of -0.01 and a beta of 1.07.

Institutional Trading of TFF Pharmaceuticals

An institutional investor recently bought a new position in TFF Pharmaceuticals stock. Armistice Capital LLC bought a new position in shares of TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 185,695 shares of the company’s stock, valued at approximately $308,000. Armistice Capital LLC owned 5.99% of TFF Pharmaceuticals as of its most recent SEC filing. Institutional investors own 15.25% of the company’s stock.

TFF Pharmaceuticals Company Profile

TFF Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.